The OPTIMAL-HT Study – Evaluation of Triple Single-Pill Combination Therapy in Achieving Stringent Blood Pressure Targets
by Prateek Chopra | June 10, 2026 | Cardiology Conferences | ESH 2026 Treatment Challenge: The 2018 ESC/ESH guidelines introduced stricter systolic BP targets (120–129 mmHg) and stepwise escalation from dual to triple therapy. Evidence for achieving <130 mmHg in patients on ≥3 antihypertensive drugs remains limited. The OPTIMAL-HT study evaluates triple single-pill combination therapy (SPC) for stringent BP control and […]